Yearbook of Oncology | ScienceGate

Minimal Disseminated Disease in High-Risk Burkitt's Lymphoma Identifies Patients With Different Prognosis

Yearbook of Oncology ◽

10.1016/j.yonc.2012.07.037 ◽

2012 ◽

Vol 2012 ◽

pp. 167-168

Author(s):

R.J. Arceci

Keyword(s):

High Risk ◽

Burkitt’S Lymphoma ◽

Burkitt's Lymphoma ◽

Minimal Disseminated Disease ◽

Disseminated Disease

Download Full-text

Association of diagnostic radiation exposure and second abdominal-pelvic malignancies after testicular cancer

Yearbook of Oncology ◽

10.1016/j.yonc.2012.05.009 ◽

2012 ◽

Vol 2012 ◽

pp. 99-100

Author(s):

C. Lawton

Keyword(s):

Testicular Cancer ◽

Radiation Exposure ◽

Pelvic Malignancies ◽

Diagnostic Radiation ◽

Diagnostic Radiation Exposure

Download Full-text

Chemoradiation and adjuvant chemotherapy in advanced cervical adenocarcinoma

Yearbook of Oncology ◽

10.1016/j.yonc.2012.08.015 ◽

2012 ◽

Vol 2012 ◽

pp. 123-124

Author(s):

J.T. Thigpen

Keyword(s):

Adjuvant Chemotherapy ◽

Cervical Adenocarcinoma

Download Full-text

Irradiation effect after mastectomy on breast cancer recurrence in patients presenting with locally advanced disease

Yearbook of Oncology ◽

10.1016/s1040-1741(12)00201-1 ◽

2012 ◽

Vol 2012 ◽

pp. 53-54

Author(s):

W.A. Hall ◽

M.A. Torres

Keyword(s):

Breast Cancer ◽

Advanced Disease ◽

Locally Advanced ◽

Cancer Recurrence ◽

Breast Cancer Recurrence ◽

Irradiation Effect ◽

Locally Advanced Disease

Download Full-text

Congenital Anomalies in the Children of Cancer Survivors: A Report From the Childhood Cancer Survivor Study

Yearbook of Oncology ◽

10.1016/j.yonc.2012.07.042 ◽

2012 ◽

Vol 2012 ◽

pp. 230-232

Author(s):

R.J. Arceci

Keyword(s):

Cancer Survivors ◽

Childhood Cancer ◽

Cancer Survivor ◽

Congenital Anomalies ◽

Childhood Cancer Survivor ◽

Childhood Cancer Survivor Study

Download Full-text

Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors

Yearbook of Oncology ◽

10.1016/j.yonc.2012.08.029 ◽

2012 ◽

Vol 2012 ◽

pp. 75-76 ◽

Cited By ~ 1

Author(s):

J.T. Thigpen

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Breast Tumors ◽

Her2 Expression ◽

Human Epidermal Growth Factor ◽

Epidermal Growth ◽

Metastatic Sites

Download Full-text

Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer

Yearbook of Oncology ◽

10.1016/j.yonc.2012.08.001 ◽

2012 ◽

Vol 2012 ◽

pp. 116-117 ◽

Cited By ~ 2

Author(s):

J.T. Thigpen

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Multicenter Study ◽

Liposomal Doxorubicin ◽

Pegylated Liposomal Doxorubicin ◽

Recurrent Ovarian Cancer ◽

Efficacy And Safety ◽

Open Label ◽

Polymerase Inhibitor ◽

Brca2 Mutations

Download Full-text

PAX3/FOXO1 Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk Stratification

Yearbook of Oncology ◽

10.1016/j.yonc.2012.07.018 ◽

2012 ◽

Vol 2012 ◽

pp. 218-219

Author(s):

R.J. Arceci

Keyword(s):

Molecular Marker ◽

Risk Stratification ◽

Fusion Gene ◽

Gene Status ◽

Current Risk

Download Full-text

Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression as a Biomarker for Patients With Advanced Non–Small-Cell Lung Cancer: the NVALT-4 Study

Yearbook of Oncology ◽

10.1016/j.yonc.2012.06.025 ◽

2012 ◽

Vol 2012 ◽

pp. 194-195

Author(s):

A.S. Tsao

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Cyclooxygenase 2 ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

Yearbook of Oncology ◽

10.1016/j.yonc.2012.06.003 ◽

2012 ◽

Vol 2012 ◽

pp. 176-177

Author(s):

C. Lawton

Keyword(s):

Lung Cancer ◽

Cancer Mortality ◽

Low Dose ◽

Lung Cancer Mortality ◽

Computed Tomographic

Download Full-text

Yearbook of Oncology
Latest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Elsevier

Minimal Disseminated Disease in High-Risk Burkitt's Lymphoma Identifies Patients With Different Prognosis

Association of diagnostic radiation exposure and second abdominal-pelvic malignancies after testicular cancer

Chemoradiation and adjuvant chemotherapy in advanced cervical adenocarcinoma

Irradiation effect after mastectomy on breast cancer recurrence in patients presenting with locally advanced disease

Congenital Anomalies in the Children of Cancer Survivors: A Report From the Childhood Cancer Survivor Study

Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors

Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer

PAX3/FOXO1 Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk Stratification

Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression as a Biomarker for Patients With Advanced Non–Small-Cell Lung Cancer: the NVALT-4 Study

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

Export Citation Format

Yearbook of OncologyLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Elsevier

Minimal Disseminated Disease in High-Risk Burkitt's Lymphoma Identifies Patients With Different Prognosis

Association of diagnostic radiation exposure and second abdominal-pelvic malignancies after testicular cancer

Chemoradiation and adjuvant chemotherapy in advanced cervical adenocarcinoma

Irradiation effect after mastectomy on breast cancer recurrence in patients presenting with locally advanced disease

Congenital Anomalies in the Children of Cancer Survivors: A Report From the Childhood Cancer Survivor Study

Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors

Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer

PAX3/FOXO1 Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk Stratification

Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression as a Biomarker for Patients With Advanced Non–Small-Cell Lung Cancer: the NVALT-4 Study

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

Yearbook of Oncology
Latest Publications